HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Van Tol, A. Articles by Joles, J. A. Search for Related Content PubMed PubMed Citation Articles by Van Tol, A. Articles by Joles, J. A. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 32, 1719-1728, Copyright © 1991 by Lipid Research, Inc.

ARTICLES

Hyperlipoproteinemia in Nagase analbuminemic rats: effects of pravastatin on plasma (apo)lipoproteins and lecithin:cholesterol acyltransferase activity

A Van Tol, EH Jansen, HA Koomans and JA Joles
Department of Biochemistry, Erasmus University, Rotterdam, The Netherlands.

The present study demonstrates very high levels of plasma lipids and high density lipoprotein (HDL) apolipoproteins (apoA-I and apoE) in female Nagase analbuminemic rats (NAR) fed a semi-synthetic diet in order to further increase the hyperlipidemia present in this strain. Plasma apoB-containing lipoproteins (very low, intermediate, and low density lipoproteins) were also elevated in NAR. Plasma cholesterol was mainly present in lipoprotein particles with a density between 1.02 and 1.12 g/ml. Separation of lipoprotein classes by gel filtration showed that the major cholesterol-carrying lipoprotein fractions in NAR plasma are apoE-rich HDL and apoA-I-rich HDL. The high HDL levels in NAR are explained, at least partly, by the two- to threefold elevated activity of plasma lecithin:cholesterol acyltransferase (LCAT). The lysophosphatidylcholine generated in the LCAT reaction, as well as plasma free fatty acids, are bound to lipoproteins in NAR plasma. A study was carried out to determine whether the elevated LDL and aopoE- rich HDL levels could be corrected by administration of the HMG-CoA reductase inhibitor pravastatin (at a dose of 1 mg/kg per day). Pravastatin treatment results in a 43% decrease in plasma triglycerides in NAR, but not in Sprague-Dawley (SDR) rats, and had no significant effect on plasma total cholesterol, phospholipids apolipoproteins A-I, A-IV, B, or E, as well as on plasma LCAT activity levels in NAR or SDR.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. M. Attia, R. Goldschmeding, M. A. Attia, P. Boer, H. A. Koomans, and J. A. Joles Male gender increases sensitivity to renal injury in response to cholesterol loading Am J Physiol Renal Physiol, April 1, 2003; 284(4): F718 - F726. [Abstract] [Full Text] [PDF]

				J. A. JOLES, U. KUNTER, U. JANSSEN, W. KRIZ, T. J. RABELINK, H. A. KOOMANS, and J. FLOEGE Early Mechanisms of Renal Injury in Hypercholesterolemic or Hypertriglyceridemic Rats J. Am. Soc. Nephrol., April 1, 2000; 11(4): 669 - 683. [Abstract] [Full Text] [PDF]

				E. Stroes, T. de Bruin, H. de Valk, W. Erkelens, J.-D. Banga, H. van Rijn, H. Koomans, and T. Rabelink NO activity in familial combined hyperlipidemia: potential role of cholesterol remnants Cardiovasc Res, December 1, 1997; 36(3): 445 - 452. [Abstract] [Full Text] [PDF]

				S. Braschi, L. Lagrost, E. Florentin, C. Martin, A. Athias, P. Gambert, M. Krempf, C. Lallemant, and B. Jacotot Increased Cholesteryl Ester Transfer Activity in Plasma From Analbuminemic Patients Arterioscler. Thromb. Vasc. Biol., March 1, 1996; 16(3): 441 - 449. [Abstract] [Full Text]